Richards-Rundle syndrome

Richards-Rundle syndrome is an extremely rare autosomal recessive neurodegenerative disorder characterized by the combination of progressive sensorineural deafness, ataxia, intellectual disability, and hypogonadism. The condition was first described by Richards and Rundle in 1959 in a family with multiple affected siblings. It affects several body systems, most notably the nervous system, the endocrine system, and the auditory system. Key clinical features include progressive cerebellar ataxia (difficulty with coordination and balance), sensorineural hearing loss that may be congenital or progressive, intellectual disability of variable severity, and hypogonadotropic hypogonadism leading to absent or incomplete sexual development. Additional neurological features may include peripheral neuropathy, muscle wasting, and horizontal nystagmus. The ICD-10 classification under G60.2 reflects the hereditary sensory and motor neuropathy component of the disease. There is currently no curative treatment for Richards-Rundle syndrome. Management is supportive and symptomatic, potentially including hearing aids or cochlear implants for hearing loss, physical and occupational therapy for ataxia and motor difficulties, hormone replacement therapy for hypogonadism, and educational support for intellectual disability. The condition is progressive, and long-term prognosis depends on the severity of neurological involvement. Given its extreme rarity, clinical experience is limited to a small number of reported families in the medical literature.

Common questions about Richards-Rundle syndrome